It just does not matter why, the market and investors hate it when directors sell large parcels of shares.
I think it damages shareholder value in the end. If they want cash, give them cash.
Anyway, will try and focus on the more positive merger/takeover senario
BGA? New CEO looking to move away from commodity end of the market, BKL JV a failure, already producing the brand...?
- Forums
- ASX - By Stock
- BAL
- stock
stock, page-1120
-
-
- There are more pages in this discussion • 178 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online